Modified risk stratification based on cervical lymph node metastases following lobectomy for papillary thyroid carcinoma
Clinical Endocrinology Nov 19, 2019
Song E, Ahn J, Song DE, et al. - In 571 individuals who had thyroid lobectomy for 1–4 cm-sized papillary thyroid carcinoma, researchers conducted this retrospective cohort study to analyze the risk of recurrence according to the present American Thyroid Association (ATA) risk stratification system. The results of this study reveal that risk stratification based on lymph node metastases alone was more reasonable to predict structural persistence/recurrence after lobectomy than that based on the overall ATA criteria. Considering the extranodal extension status, individuals with a high risk of recurrence can be selected to minimize further treatments.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries